The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit againstMolina Healthcare, Inc. (“Molina” or “the Company”) (NYSE: MOH) forviolations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. https://mma.prnewswire.com/media/1396534/Schall_Firm_Logo.jpg Investors who purchased the […]

Cheung Kong Graduate School of Business (CKGSB) celebrates its 23rd anniversary with the unveiling of its first permanent Beijing campus. For the first time since its founding on November 21, 2002, the school will have a permanent home – a space that represents its identity as an innovative management education hub and its commitment to

The DJS Law Group reminds investors of a class action lawsuit against CarMax, Inc. (“CarMax ” or “the Company”) (NYSE: KMX ) violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of KMX during the class

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit againstJayud Global Logistics Limited (“Jayud” or “the Company”) (NASDAQ: JYD) forviolations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. https://mma.prnewswire.com/media/1396534/Schall_Firm_Logo.jpg Investors who purchased

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit againstCarMax, Inc. (“CarMax” or “the Company”) (NYSE: KMX) forviolations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. https://mma.prnewswire.com/media/1396534/Schall_Firm_Logo.jpg Investors who purchased the Company's

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit againstFreeport-McMoRan Inc. (“Freeport” or “the Company”) (NYSE: FCX)forviolations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. https://mma.prnewswire.com/media/1396534/Schall_Firm_Logo.jpg Investors who purchased the Company's securities

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors ofHormel Foods Corporation (“Hormel” or “the Company”) (NYSE: HRL) for violations of the securities laws. https://mma.prnewswire.com/media/1396534/Schall_Firm_Logo.jpg The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to

NEW YORK, NY / ACCESS Newswire / November 24, 2025 / If you suffered a loss on your Synopsys, Inc. (NASDAQ:SNPS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/synopsys-inc-lawsuit-submission-form?prid=178826&wire=1&utm_campaign=3 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

NEW YORK, NY / ACCESS Newswire / November 24, 2025 / If you suffered a loss on your Inspire Medical Systems, Inc. (NYSE:INSP) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/inspire-medical-systems-inc-lawsuit-submission-form?prid=178825&wire=1&utm_campaign=26 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com

Preclinical Results Demonstrate Complete Response and Tumor Regression in ACC PDX Models Pin Therapeutics, a clinical-stage biotechnology company specializing in targeted protein degradation, announced on November 20 that it has administered the first dose of its CK1a-selective degrader PIN-5018 in a Phase 1 clinical trial. The first patient enrolled has adenoid cystic carcinoma (ACC), a